Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

4SC AG (XETRA: VSC)

 
VSC Technical Analysis
4
As on 10th Feb 2023 VSC STOCK Price closed @ 2.50 and we RECOMMEND Sell for LONG-TERM with Stoploss of 3.05 & Strong Sell for SHORT-TERM with Stoploss of 4.83 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

VSCSTOCK Price

Open 2.50 Change Price %
High 2.50 1 Day -0.48 -16.11
Low 2.50 1 Week 0.24 10.62
Close 2.50 1 Month 1.18 89.39
Volume 11 1 Year -2.70 -51.92
52 Week High 5.40 | 52 Week Low 1.20
 
XETRA Germany Most Active Stocks
LHAR 2.05 -20.23%
BBVA 5.00 -2.72%
BBVA 5.00 -2.72%
BBVA 5.00 -2.72%
BVBA 0.02 -60.00%
SNH 0.16 6.67%
SNH 0.16 6.67%
SNH 0.16 6.67%
PHIA 31.36 1.92%
PHIA 31.36 1.92%
 
XETRA Germany Top Gainers Stocks
PDA 2.73 196.74%
PDA 2.73 196.74%
PDA 2.73 196.74%
PDA 2.73 196.74%
PDA 2.73 196.74%
PDA 2.73 196.74%
PAG 0.02 100.00%
PAG 0.02 100.00%
PAG 0.02 100.00%
PAG 0.02 100.00%
 
XETRA Germany Top Losers Stocks
F03 0.56 -99.14%
F03 0.56 -99.14%
F03 0.56 -99.14%
F03 0.56 -99.14%
IQL 0.02 -66.67%
IQL 0.02 -66.67%
EIN3 60.20 -63.95%
EIN3 60.20 -63.95%
EIN3 60.20 -63.95%
LEO 0.04 -63.64%
 
 
VSC
Daily Charts		 VSC
Intraday Charts		 Whats New @
Bazaartrend		 VSC
Free Analysis
 
VSC Important Levels Intraday
RESISTANCE2.50
RESISTANCE2.50
RESISTANCE2.50
RESISTANCE2.50
RESISTANCE2.50
RESISTANCE2.50
RESISTANCE2.50
RESISTANCE2.50
 
VSC Forecast November 2024
Share
4th UP Forecast5.08
3rd UP Forecast4.25
2nd UP Forecast3.74
1st UP Forecast3.23
1st DOWN Forecast1.77
2nd DOWN Forecast1.26
3rd DOWN Forecast0.75
4th DOWN Forecast-0.08
 
VSC Weekly Forecast
4th UP Forecast3.25
3rd UP Forecast3.01
2nd UP Forecast2.86
1st UP Forecast2.71
1st DOWN Forecast2.29
2nd DOWN Forecast2.14
3rd DOWN Forecast1.99
4th DOWN Forecast1.75
 
VSC Forecast2024
4th UP Forecast10.65
3rd UP Forecast8.04
2nd UP Forecast6.42
1st UP Forecast4.81
1st DOWN Forecast0.19
2nd DOWN Forecast-1.42
3rd DOWN Forecast-3.04
4th DOWN Forecast-5.65
 
 
VSC Other Details
Segment EQ
Market Capital 228323536.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
VSC Address
VSC
 
VSC Latest News
 
Your Comments and Response on 4SC AG
 
VSC Business Profile
4SC AG, a clinical-stage biopharmaceutical company, engages in developing small-molecule drugs that target key indications in cancer with high unmet medical needs. The company's products in clinical development stage include Resminostat, an orally administered histone deacetylase inhibitor that is in Phase II clinical trial for the treatment of cutaneous T-cell lymphoma; and Domatinostat, an orally administered small molecule, which is in Phase Ib/II clinical trial for the treatment of melanoma and Phase II clinical trial for the treatment of gastrointestinal tumor. 4SC AG also out-licenses its products to pharma and biotech companies for the treatment of cancer. The company has a collaboration agreement with the Netherlands Cancer Institute to evaluate Domatinostat in the neoadjuvant setting in melanoma. 4SC AG was founded in 1997 and is headquartered in Planegg, Germany. Address: Fraunhoferstrasse 22, Planegg, Germany, 82152
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service